Clinical Supply Planning Resources
-
Key Capabilities For Clinical Supply Efficiency
3/13/2026
Explore key considerations for planning clinical supply packaging and distribution in Europe to help balance cost, flexibility, and scheduling while supporting efficient trial execution.
-
Effective Use Of IRT In Decentralized And Hybrid Clinical Trials
1/5/2023
Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.
-
Navigate Complex Ancillary Supply Sourcing Challenges
8/1/2022
Explore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
-
Global Clinical Supply Solutions For Every Trial
A reliable clinical supply chain strategy is as essential as a company’s discovery program. Seek a partner who can help guide a comprehensive strategy and manage day-to-day activities.
-
Hidden Benefits Of Clinical Forecasting & Supply Planning Solutions
9/18/2024
Streamline clinical supply chain management with SmartSignals Supplies, reducing errors and inefficiencies from spreadsheet-based forecasting.
-
Specialized Expertise For Efficient Management Of Clinical Supply Budgets
7/13/2022
A financial project analyst (FPA) plays a critical role in clinical trial supply and budget management. Explore how sponsors can benefit from having this specialist on their supply partner's team.
-
FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study
3/12/2026
Adopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.
-
How To Avoid Delays In Clinical Supply: Strategies For Comparator Sourcing
5/5/2022
Learn about the ways in which sponsors can work effectively with clinical suppliers for accurate forecasting and comparator sourcing.
-
IMP Labeling: EU CTR Transition Considerations
6/26/2023
Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.
-
Planning For The Return And Destruction Of Your Product
8/24/2022
Aspects of accountability, reconciliation, return, and destruction require significant effort to compile historical data. A little up-front planning can remove many future complications.